| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |